# TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men

Study · id `cardio:ct-nct07460960` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07460960](<https://clinicaltrials.gov/study/NCT07460960>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07460960

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.

## Technical summary

Registry record NCT07460960. Randomized; no masking; primary purpose other. Start 2026-03-05 (actual); primary completion 2027-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose other
- Phase: Phase 2
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT07460960, source copy `cardio:ctgov-nct07460960-2026-03-16`, retrieved 2026-10-26)
- Started: 2026-03-05 (actual) (ClinicalTrials.gov record NCT07460960, source copy `cardio:ctgov-nct07460960-2026-03-16`, retrieved 2026-10-26)
- Primary completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT07460960, source copy `cardio:ctgov-nct07460960-2026-03-16`, retrieved 2026-10-26)
- Completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT07460960, source copy `cardio:ctgov-nct07460960-2026-03-16`, retrieved 2026-10-26)
- Countries: Russia (ClinicalTrials.gov record NCT07460960, source copy `cardio:ctgov-nct07460960-2026-03-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07460960-2026-03-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men
- Condition: Erectile Dysfunction Due to Arterial Disease
- Condition: Atheroscleroses
- Condition: Erectile Disfunction
- Condition: Endothelial Dysfunction
- Condition: Androgen Profile
- Condition: Testosterone
- Intervention (Drug): Pitavastatin 1-4 mg daily
- Intervention (Drug): Rosuvastatin 20-40 mg daily
- Lead sponsor: Lomonosov Moscow State University Medical Research and Educational Center
- Lead sponsor class: OTHER
- Collaborator: Nizhpharm
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)

## Provenance

Content hash: c8265dfd47fa7d11bdec3d17f818133c05612dfc474af9abf42cb7c34b016ae6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
